CIK 0000885590 · Large accelerated filer
Bausch Health Companies Inc.
Sign in to watch- Ticker
- BHC
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NJ
- Entity type
- operating
- Phone
- 514-744-6792
- Business address
- 2150 ST. ELZEAR BLVD. WEST, LAVAL, QUEBEC, Quebec, Canada, H7L 4A8
- Former names
- Valeant Pharmaceuticals International, Inc., BIOVAIL Corp, BIOVAIL CORP INTERNATIONAL, BIOVAIL CORPORATION INTERNATIONAL
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $258,894
- in 1 filing, $259K under 10b5-1 plans
Net −$258,894. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-08 | Herendeen Paul EVP and CFO | Grant or award | +50,518 | 446,137 | ||
| 2021-03-08 | Herendeen Paul EVP and CFO | Option exercise · Restricted Share Units | −49,324 | 0 | ||
| 2021-03-08 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Option exercise | +5,637 | 105,779 | ||
| 2021-03-08 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Grant or award | +17,320 | 123,099 | ||
| 2021-03-08 | Gordon Joseph F Pres&Co-Head Bausch&Lomb/Int'l | Option exercise · Restricted Share Units | −5,637 | 0 | ||
| 2021-03-08 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Option exercise | +4,404 | 94,015 | ||
| 2021-03-08 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Grant or award | +13,530 | 107,545 | ||
| 2021-03-08 | Eldessouky Sam SVP, CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Units | −4,404 | 0 | ||
| 2021-03-08 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Option exercise | +9,161 | 219,762 | ||
| 2021-03-08 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Grant or award | +28,144 | 247,906 | ||
| 2021-03-08 | APPIO THOMAS Pres&Co-Head Bausch&Lomb/Int'l | Option exercise · Restricted Share Units | −9,161 | 0 | ||
| 2021-03-08 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise | +8,455 | 163,534 | ||
| 2021-03-08 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Grant or award | +25,980 | 189,514 | ||
| 2021-03-08 | ACKERMANN CHRISTINA EVP AND GENERAL COUNSEL | Option exercise · Restricted Share Units | −8,455 | 0 | ||
| 2021-03-03 | Spurr Robert President, Salix | Grant or award | +23,892 | 59,336 | ||
| 2021-03-03 | Spurr Robert President, Salix | Grant or award · Non-qualified Stock Options (right To Purchase) | +32,749 | 32,749 | ||
| 2021-03-03 | PAPA JOSEPH C CHAIRMAN & CEO | Grant or award | +74,150 | 845,823 | ||
| 2021-03-03 | PAPA JOSEPH C CHAIRMAN & CEO | Grant or award · Non-qualified Stock Options (right To Purchase) | +196,464 | 196,464 | ||
| 2021-03-03 | Herendeen Paul EVP and CFO | Grant or award | +63,439 | 346,295 | ||
| 2021-03-03 | Herendeen Paul EVP and CFO | Grant or award · Non-qualified Stock Options (right To Purchase) | +91,684 | 91,684 |
Page 22 of 23 · 453 trades